Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)Price and VolumeDetailed Quote
Top NewsMore News
Performance
52-Week Range
33.9% below 52-week high
28.51
25.7752W Low
43.1552W High
1 Week
5.5% below 1-week high
27.051W Low
30.181W High
Viking Therapeutics, Inc. - Common Stock (VKTX) traded between $25.77 and $43.15 over the past 52 weeks and last traded at $28.51, 33.9% below its 52-week high. Over the past week it ranged between $27.05 and $30.18.
Past 12 Months
-2.6%
-12.8%
-26.6%
-16.8%
-19.5%
-18.5%
1W
-$0.77
1M
-$4.19
3M
-$10.35
6M
-$5.75
YTD
-$6.91
1Y
-$6.47
VKTX was -18.5% over the past year, -16.8% over six months, -19.5% year to date, -2.6% in the last week.
12 Months vs Market
VKTX
DIA
SPY
QQQ
IWM
Over the past 12 months VKTX returned -18.5% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +23.0% and IWM (Russell 2000) +13.8%.
Volume & Liquidity
0.98× 3-mo avg
Today 4,045,855
3-mo avg 4.1M
1W
1M
3M
6M
YTD
1Y
VKTX most recently traded 4,045,855 shares against a 3-month average daily volume of 4.1M. More NewsRead More
Prediction: This Stock Could Double Over the Next 5 Years ↗
October 02, 2026
Via The Motley Fool
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy ↗
September 30, 2026
Via The Motley Fool
Topics
Initial Public Offering
3 Emerging Biotech Stocks With Significant Upside Potential ↗
September 30, 2026
Via MarketBeat
Topics
Intellectual Property
3 Non-AI Growth Stocks That Have Massive Upside ↗
September 29, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly? ↗
September 28, 2026
Via The Motley Fool
MarketBeat Week in Review – 09/21 - 09/25 ↗
September 26, 2026
Via MarketBeat
Via The Motley Fool
Here's Why Viking Therapeutics Shares Slumped Today ↗
September 24, 2026
Via The Motley Fool
Viking's Obesity Edge May Be Staying Power, Not Weight Loss ↗
September 23, 2026
Via MarketBeat
Why Viking Therapeutics Stock Skyrocketed on Tuesday ↗
September 23, 2026
Via The Motley Fool
Which stocks are experiencing notable movement on Tuesday? ↗
September 22, 2026
Via Chartmill
What's going on in today's session ↗
September 22, 2026
Via Chartmill
Gapping stocks in Tuesday's session ↗
September 22, 2026
Via Chartmill
Viking Therapeutics’ VK2735 Shows Strong Weight-Loss Retention With Monthly Dosing ↗
September 22, 2026
Via MarketBeat
Tuesday's pre-market session: top gainers and losers ↗
September 22, 2026
Via Chartmill
Viking Therapeutics Advances VK2735 Obesity Drug Into Phase 3 After 15% Weight Loss ↗
September 14, 2026
Via MarketBeat
Via The Motley Fool
Frequently Asked QuestionsIs Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 28.51
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 10/09/26 04:00 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.84B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>